Control | Placebo injection with physiotherapy | Corticosteroid injection with physiotherapy | P | |
---|---|---|---|---|
(n = 60) | (n = 58) | Chi‐square test | ||
Paid sick leave during 52 week follow‐up | ||||
Number (percentage) on leave | 30 (52) | 31 (56) | 30 (55) | 0.88 |
Duration of leave for those on sick‐leave: | ||||
Days on full leave mean (95 % CI) | 43.6 (22.0 to 65.1) | 73.2 (34.2 to 112.2) | 47.1 (30.0 to 64.3) | 0.25* |
Days on partial leave mean (95 % CI) | 60.0 (23.1 to 96.9) | 22.0 (6.8 to 37.3) | 29.2 (11.2 to 47.2) | 0.07* |
Additional treatments | ||||
Number of patients receiving additional treatments | 13 (23) | 12 (22) | 16 (30) | 0.63 |
Type of treatment: | ||||
Pain killers | 6 (11) | 4 (7) | 2 (4) | 0.37 |
NSAIDs perorally | 7 (13) | 9 (16) | 11 (20) | 0.54 |
topical NSAIDs | 3 (5) | 1 (2) | 2 (4) | 0.62 |
other medication | 3 (6) | 0 (0) | 3 (6) | 0.22 |
physiotherapy | 4 (7) | 1 (2) | 9 (17) | 0.02+ |
other | 6 (11) | 4 (7) | 4 (8) | 0.76 |
Adverse Events | ||||
Patients reporting adverse events | 9 (16) | 5 (9) | 6 (11) | 0.51 |
Type of adverse events | ||||
increased pain | 2 (4) | 2 (4) | 0 (0) | 0.37 |
GI side effects** | 8 (15) | 3 (6) | 6 (11) | 0.30 |
skin atrophy | 0 (0) | 0 (0) | 0 (0) | ‐ |